In focus
Latest feed
AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology
AI‑Designed Universal COVID‑19 Vaccine Enters Phase‑1 Trials
The Man Who Unlocked Our Allergies: Charles Richet and Anaphylaxis
The Quest for Hair: Nektar's Rezpeg Promises a New Dawn for Alopecia Sufferers
